235 related articles for article (PubMed ID: 27157912)
1. Malate-aspartate shuttle inhibitor aminooxyacetic acid leads to decreased intracellular ATP levels and altered cell cycle of C6 glioma cells by inhibiting glycolysis.
Wang C; Chen H; Zhang M; Zhang J; Wei X; Ying W
Cancer Lett; 2016 Aug; 378(1):1-7. PubMed ID: 27157912
[TBL] [Abstract][Full Text] [Related]
2. Malate-Aspartate Shuttle Inhibitor Aminooxyacetate Acid Induces Apoptosis and Impairs Energy Metabolism of Both Resting Microglia and LPS-Activated Microglia.
Chen H; Wang C; Wei X; Ding X; Ying W
Neurochem Res; 2015 Jun; 40(6):1311-8. PubMed ID: 25998884
[TBL] [Abstract][Full Text] [Related]
3. Malate-aspartate shuttle, cytoplasmic NADH redox potential, and energetics in vascular smooth muscle.
Barron JT; Gu L; Parrillo JE
J Mol Cell Cardiol; 1998 Aug; 30(8):1571-9. PubMed ID: 9737943
[TBL] [Abstract][Full Text] [Related]
4. Aminooxyacetic acid inhibits the malate-aspartate shuttle in isolated nerve terminals and prevents the mitochondria from utilizing glycolytic substrates.
Kauppinen RA; Sihra TS; Nicholls DG
Biochim Biophys Acta; 1987 Sep; 930(2):173-8. PubMed ID: 3620514
[TBL] [Abstract][Full Text] [Related]
5. The operation of the malate-aspartate shuttle in the reoxidation of glycolytic NADH in slices of fetal rat liver.
Dani A; Bartoli GM; Galeotti T
Biochim Biophys Acta; 1977 Dec; 462(3):781-4. PubMed ID: 202312
[TBL] [Abstract][Full Text] [Related]
6. Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools.
McKenna MC; Waagepetersen HS; Schousboe A; Sonnewald U
Biochem Pharmacol; 2006 Feb; 71(4):399-407. PubMed ID: 16368075
[TBL] [Abstract][Full Text] [Related]
7. Substrate-dependent utilization of the glycerol 3-phosphate or malate/aspartate redox shuttles by Ehrlich ascites cells.
Grivell AR; Korpelainen EI; Williams CJ; Berry MN
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):665-71. PubMed ID: 7654209
[TBL] [Abstract][Full Text] [Related]
8. A Ca
Pérez-Liébana I; Juaristi I; González-Sánchez P; González-Moreno L; Rial E; Podunavac M; Zakarian A; Molgó J; Vallejo-Illarramendi A; Mosqueira-Martín L; Lopez de Munain A; Pardo B; Satrústegui J; Del Arco A
J Neurosci; 2022 May; 42(19):3879-3895. PubMed ID: 35387872
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the oxidation of glycolytic NADH by the malate-aspartate shuttle in Ehrlich ascites tumor cells.
López-Alarcón L; Eboli ML; De Liberali E; Palombini G; Galeotti T
Arch Biochem Biophys; 1979 Feb; 192(2):391-5. PubMed ID: 219778
[No Abstract] [Full Text] [Related]
10. Silencing of the mitochondrial NADH shuttle component aspartate-glutamate carrier AGC1/Aralar1 in INS-1E cells and rat islets.
Casimir M; Rubi B; Frigerio F; Chaffard G; Maechler P
Biochem J; 2009 Dec; 424(3):459-66. PubMed ID: 19764902
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of the malate-aspartate shuttle in various tumor types.
Greenhouse WV; Lehninger AL
Cancer Res; 1976 Apr; 36(4):1392-6. PubMed ID: 177206
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of reduced cytosolic nicotinamide adenine dinucleotide by the malate-aspartate shuttle in the K-562 human leukemia cell line.
López-Alarcón L; Eboli ML
Cancer Res; 1986 Nov; 46(11):5589-91. PubMed ID: 3756905
[TBL] [Abstract][Full Text] [Related]
13. Magnitude of malate-aspartate reduced nicotinamide adenine dinucleotide shuttle activity in intact respiring tumor cells.
Greenhouse WV; Lehninger AL
Cancer Res; 1977 Nov; 37(11):4173-81. PubMed ID: 198130
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection.
Støttrup NB; Løfgren B; Birkler RD; Nielsen JM; Wang L; Caldarone CA; Kristiansen SB; Contractor H; Johannsen M; Bøtker HE; Nielsen TT
Cardiovasc Res; 2010 Nov; 88(2):257-66. PubMed ID: 20562422
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the malate-aspartate shuttle in mouse pancreatic islets abolishes glucagon secretion without affecting insulin secretion.
Stamenkovic JA; Andersson LE; Adriaenssens AE; Bagge A; Sharoyko VV; Gribble F; Reimann F; Wollheim CB; Mulder H; Spégel P
Biochem J; 2015 May; 468(1):49-63. PubMed ID: 25731850
[TBL] [Abstract][Full Text] [Related]
16. Saturation of the mitochondrial NADH shuttles drives aerobic glycolysis in proliferating cells.
Wang Y; Stancliffe E; Fowle-Grider R; Wang R; Wang C; Schwaiger-Haber M; Shriver LP; Patti GJ
Mol Cell; 2022 Sep; 82(17):3270-3283.e9. PubMed ID: 35973426
[TBL] [Abstract][Full Text] [Related]
17. Disruption of mitochondrial malate-aspartate shuttle activity in mouse blastocysts impairs viability and fetal growth.
Mitchell M; Cashman KS; Gardner DK; Thompson JG; Lane M
Biol Reprod; 2009 Feb; 80(2):295-301. PubMed ID: 18971426
[TBL] [Abstract][Full Text] [Related]
18. Fluctuations in Cytosolic Calcium Regulate the Neuronal Malate-Aspartate NADH Shuttle: Implications for Neuronal Energy Metabolism.
Satrústegui J; Bak LK
Neurochem Res; 2015 Dec; 40(12):2425-30. PubMed ID: 26138554
[TBL] [Abstract][Full Text] [Related]
19. The cardioprotective effect of sildenafil is mediated by the activation of malate dehydrogenase and an increase in the malate-aspartate shuttle in cardiomyocytes.
Gevi F; Campolo F; Naro F; Zolla L
Biochem Pharmacol; 2017 Mar; 127():60-70. PubMed ID: 28017777
[TBL] [Abstract][Full Text] [Related]
20. Malate-aspartate shuttle inhibitor aminooxyacetic acid blocks lipopolysaccharides-induced activation of BV2 microglia.
Shang W; Wei X; Ying W
Int J Physiol Pathophysiol Pharmacol; 2017; 9(2):58-63. PubMed ID: 28533892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
